W

hen Dr. Scott Gottlieb pledged at his confirmation hearing to uphold a “gold standard of safety and efficacy” at the Food and Drug Administration, he raised an important question:

What exactly does he mean by that?

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • LD50 studies remain imperative
    to be done in mice; and clinical trials to be done in humans who volunteer, including physicians,
    okay!

Sign up for our Biotech newsletter — The Readout

Your daily guide to what’s new in biotech.